- Report
- August 2024
- 180 Pages
Asia Pacific
From €3614EUR$3,869USD£3,058GBP
- Report
- September 2023
- 303 Pages
Global
From €4833EUR$5,354USD£3,950GBP
- Report
- May 2023
- 147 Pages
Global
From €4623EUR$4,949USD£3,911GBP
- Report
- December 2023
- 160 Pages
United States
From €2606EUR$2,789USD£2,204GBP
- Report
- October 2023
- 158 Pages
Latin America
From €3699EUR$3,959USD£3,129GBP
- Report
- August 2023
- 145 Pages
Global
From €2943EUR$3,150USD£2,490GBP
- Report
- September 2023
- 87 Pages
Africa, Middle East
From €2756EUR$2,950USD£2,331GBP
- Report
- September 2023
- 89 Pages
From €2756EUR$2,950USD£2,331GBP
- Report
- September 2023
- 112 Pages
Europe
From €3223EUR$3,450USD£2,727GBP
- Report
- September 2023
- 101 Pages
North America
From €2756EUR$2,950USD£2,331GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$4,013USD£3,065GBP
- Report
- November 2022
- 310 Pages
Global
From €3587EUR$3,840USD£3,035GBP

The Paediatric Vaccine market is a subset of the Vaccine market, focusing on the development and distribution of vaccines for children. Vaccines are a key tool in the prevention of infectious diseases, and are especially important for children, who are more vulnerable to the effects of these diseases. Vaccines are typically administered in a series of doses, and are often required for school entry.
The Paediatric Vaccine market is highly regulated, with stringent safety and efficacy standards in place. Vaccines are typically developed by pharmaceutical companies, and then approved and distributed by government health authorities. Vaccines are often provided free of charge to children, and are also available for purchase in some countries.
Notable companies in the Paediatric Vaccine market include Pfizer, Merck, Sanofi, GlaxoSmithKline, and Johnson & Johnson. Show Less Read more